Probiotic compositions and methods for inducing and supporting weight loss

• US 9,371,510 B2
• Filed: 10/21/2008
• Issued: 06/21/2016
• Est. Priority Date: 10/26/2007
• Status: Active Grant

• Current Assignee: Brenda E. Moore
• Original Assignee: Brenda E. Moore
• Inventors: Moore, Brenda E.
• Primary Examiner(s): CHOWDHURY, IQBAL HOSSAIN
• Application Number:
  US12/255,152
• Publication Number:
  US 20090110664A1
• Time in Patent Office: 2,800 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: A61K 35/741 Probiotics probiotic yeast, e.g. saccharomyces A61K36/06
• CPC Class Codes: A61P 3/04 Anorexiants; Antiobesity agents
• CPC Class Codes: C12N 1/20 Bacteria; Culture media therefor

Abstract

A probiotic composition for inducing or supporting weight loss in a subject, the probiotic composition including an effective amount of a bacteria selected from the genus Bacteroides and a carrier for delivering the bacteria to the subject.

Claims

1. A probiotic composition comprising:

probiotic bacteria that consists of bacteria selected from the genus Bacteroides, wherein;

the probiotic bacteria are;

rendered dormant;

present in a select one of a semi-solid, a cake, and a powdered form; and

present in an amount effective to induce or support weight loss, or prevent or reduce weight gain; and

a pharmaceutically acceptable carrier implemented as a non-liquid substance in the form of a tableting agent to facilitate administration of the dormant probiotic bacteria to a subject, wherein the pharmaceutically acceptable carrier contains the dormant probiotic bacteria therein until the dormant probiotic bacteria is delivered to a gastrointestinal tract of a subject.

2. The probiotic composition of claim 1, wherein the pharmaceutically acceptable carrier is implemented as a polymer matrix.

3. The probiotic composition of claim 1, wherein the composition is in the form of a gelatin capsule, and the probiotic bacteria are rendered dormant via lyophilization.

4. The probiotic composition of claim 1, wherein the dormant probiotic bacteria are present in the composition at a quantity of at least 1,000,000 colony forming units per gram, based upon the total weight of the composition.

5. The probiotic composition of claim 1, wherein the bacteria selected from the genus Bacteroides is selected from the group consisting of Bacteroides thetaiotaomicron, B. fragilis, B. vulgatus, B. distasonis, B. ovatus, B. stercoris, B. merda, B. uniformis, B. eggerithii, and B. caccae.

6. The probiotic composition of claim 1, wherein the genus Bacteroides bacteria is dried.

7. The probiotic composition of claim 1, further comprising:

a protectant that provides cell protection of the probiotic bacteria prior to lyophilization.

8. The probiotic composition of claim 7, wherein the protectant is selected from the group consisting of distilled water, polyethylene glycol, sucrose, trehalose, skim milk, xylose, hemicellulose, pectin, amylose, amylopectin, xylan, arabinogalactan, starch, and polyvinylpyrrolidone.

9. The probiotic composition of claim 1, further comprising a pharmaceutically acceptable excipient for protecting and preserving the dormant probiotic bacteria contained in the pharmaceutically acceptable carrier until the pharmaceutically acceptable carrier containing the dormant probiotic bacteria is delivered to a gastrointestinal tract of a subject.

10. The probiotic composition of claim 9, wherein the pharmaceutically acceptable excipient is selected from the group consisting of microcrystalline cellulose, mannitol, glucose, defatted milk powder, polyvinylpyrrolidone, and starch.

11. The probiotic composition of claim 1, wherein the tableting agent comprises at least one of dibasic calcium phosphate, stearic acid, croscarmellose, silica, cellulose and cellulose coating.